AI is about to change healthcare. These 6 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
To own HIVE today, you have to buy into a story that it can evolve from a volatile, unprofitable Bitcoin miner into a scaled AI infrastructure provider with long term, contracted GPU demand. The newly announced C$3.50 billion, 320 MW AI gigafactory near Toronto is central to that shift, and the sharp share price move suggests this pivot has quickly become the key short term catalyst, eclipsing earlier drivers like incremental BUZZ deployments, Paraguay expansion and smaller fiber upgrades. At the same time, it magnifies existing risks around persistent losses, dilution from past and potential future capital raises, and execution on a very large, multi year build that is not yet revenue producing. The Nasdaq driven governance tweaks are helpful for credibility but are unlikely to move the needle compared with the gigafactory plan.
Yet behind the excitement, one financing risk in particular deserves closer attention from shareholders.
In light of our recent valuation report, it seems possible that HIVE Digital Technologies is trading beyond its estimated value.Six fair value estimates from the Simply Wall St Community span roughly US$4.41 to US$32.44, highlighting just how far apart individual views are. Against that backdrop, the C$3.50 billion AI gigafactory plan, recent price surge and ongoing losses give you plenty of reasons to weigh several competing interpretations of what HIVE’s new direction could mean.
Explore 6 other fair value estimates on HIVE Digital Technologies - why the stock might be worth 22% less than the current price!
Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.
Don't miss your shot at the next 10-bagger. Our latest stock picks just dropped:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com